|
|
||||||||
Departments of Neurology (Drs. Serban, Taraboulos, DeArmond, Prusiner), Pathology (Dr. DeArmond), and Biochemistry and Biophysics (Dr. Prusiner), University of California, San Francisco, CA.
Creutzfeldt-Jakob disease (CJD) and Gerstmann-Sträussler syndrome (GSS) of humans as well as scrapie of animals are caused by prions. The scrapie prion protein isoform (PrPSc) is the only macromolecule identified to date which is a component of the infectious prion particle. PrPSc is converted to PrP 27-30 by limited proteolysis while the cellular isoform, designated PrPc, is completely digested under the same conditions. ELISA studies demonstrated that native PrP 27-30 bound to plastic surfaces resisted proteolysis and exhibited little or no immunoreactivity but after denaturation with guanidinium thiocyanate (GdnSCN), immunoreactivity was greatly enhanced. PrPSc bound to nitrocellulose also exhibited enhanced immunoreactivity after denaturation. PrPSc was readily detected in brain extracts from scrapie-infected hamsters, mice, and sheep by dot-blot immunoassays using limited proteolysis followed by GdnSCN denaturation. The high sensitivity and specificity of the immunoassay allowed detection of regional differences in PrPSc in sheep brain. CJD prion protein isoform (PrPCJD) was also detected in the brains of all 10 patients tested with neuropathologically confirmed CJD and in 1 patient with GSS. Enhanced immunoreactivity of PrPSc or PrPCJD after denaturation cannot only be used for immunodiagnosis of prion diseases but may also form the basis of new assays in experimental studies directed at the chemical structure of the prion particle.
Address correspondence and reprint requests to Dr. Stanley B. Prusiner, Department of Neurology, HSE-781, University of California, San Francisco CA 94143-0518.
A.T. is recipient of a fellowship from the John Douglas French Foundation. Supported by research grants from the National Institutes of Health (AG02132 and NS14069) and a Senator Jacob Javits Center of Excellence in Neuroscience (NS22786) as well as by gifts from the Sherman Fairchild Foundation and the American Health Assistance Foundation.
Received July 19, 1989. Accepted for publication in final form August 31, 1989.
This article has been cited by other articles:
![]() |
J. D. F. Wadsworth, S. Joiner, J. M. Linehan, M. Desbruslais, K. Fox, S. Cooper, S. Cronier, E. A. Asante, S. Mead, S. Brandner, et al. Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice PNAS, March 11, 2008; 105(10): 3885 - 3890. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Barmada and D. A. Harris Visualization of Prion Infection in Transgenic Mice Expressing Green Fluorescent Protein-Tagged Prion Protein J. Neurosci., June 15, 2005; 25(24): 5824 - 5832. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Tremblay, H. L. Ball, K. Kaneko, D. Groth, R. S. Hegde, F. E. Cohen, S. J. DeArmond, S. B. Prusiner, and J. G. Safar Mutant PrPSc Conformers Induced by a Synthetic Peptide and Several Prion Strains J. Virol., February 15, 2004; 78(4): 2088 - 2099. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Heller, K. F. Winklhofer, J. Heske, A. Reintjes, and J. Tatzelt Post-translational Import of the Prion Protein into the Endoplasmic Reticulum Interferes with Cell Viability: A CRITICAL ROLE FOR THE PUTATIVE TRANSMEMBRANE DOMAIN J. Biol. Chem., September 19, 2003; 278(38): 36139 - 36147. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Perrier, K. Kaneko, J. Safar, J. Vergara, P. Tremblay, S. J. DeArmond, F. E. Cohen, S. B. Prusiner, and A. C. Wallace Dominant-negative inhibition of prion replication in transgenic mice PNAS, October 1, 2002; 99(20): 13079 - 13084. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Bosque, C. Ryou, G. Telling, D. Peretz, G. Legname, S. J. DeArmond, and S. B. Prusiner Prions in skeletal muscle PNAS, March 19, 2002; 99(6): 3812 - 3817. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Mastrianni, S. Capellari, G. C. Telling, D. Han, P. Bosque, S. B. Prusiner, and S. J. DeArmond Inherited prion disease caused by the V210I mutation: Transmission to transgenic mice Neurology, December 26, 2001; 57(12): 2198 - 2205. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Peretz, M. R. Scott, D. Groth, R. A. Williamson, D. R. Burton, F. E. Cohen, and S. B. Prusiner Strain-specified relative conformational stability of the scrapie prion protein Protein Sci., April 1, 2001; 10(4): 854 - 863. [Abstract] [Full Text] |
||||
![]() |
S. Supattapone, T. Muramoto, G. Legname, I. Mehlhorn, F. E. Cohen, S. J. DeArmond, S. B. Prusiner, and M. R. Scott Identification of Two Prion Protein Regions That Modify Scrapie Incubation Time J. Virol., February 1, 2001; 75(3): 1408 - 1413. [Abstract] [Full Text] |
||||
![]() |
A. F. Hill, S. Joiner, J. Linehan, M. Desbruslais, P. L. Lantos, and J. Collinge Species-barrier-independent prion replication in apparently resistant species PNAS, August 29, 2000; 97(18): 10248 - 10253. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Perrier, A. C. Wallace, K. Kaneko, J. Safar, S. B. Prusiner, and F. E. Cohen Mimicking dominant negative inhibition of prion replication through structure-based drug design PNAS, May 23, 2000; 97(11): 6073 - 6078. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zulianello, K. Kaneko, M. Scott, S. Erpel, D. Han, F. E. Cohen, and S. B. Prusiner Dominant-Negative Inhibition of Prion Formation Diminished by Deletion Mutagenesis of the Prion Protein J. Virol., May 1, 2000; 74(9): 4351 - 4360. [Abstract] [Full Text] |
||||
![]() |
S. Supattapone, H.-O. B. Nguyen, F. E. Cohen, S. B. Prusiner, and M. R. Scott Elimination of prions by branched polyamines and implications for therapeutics PNAS, December 7, 1999; 96(25): 14529 - 14534. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shaked, H. Rosenmann, G. Talmor, and R. Gabizon A C-terminal-truncated PrP Isoform Is Present in Mature Sperm J. Biol. Chem., November 5, 1999; 274(45): 32153 - 32158. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Meyer, B. Oesch, R. Fatzer, A. Zurbriggen, and M. Vandevelde Detection of Bovine Spongiform Encephalopathy-Specific PrPSc by Treatment with Heat and Guanidine Thiocyanate J. Virol., November 1, 1999; 73(11): 9386 - 9392. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Naslavsky, H. Shmeeda, G. Friedlander, A. Yanai, A. H. Futerman, Y. Barenholz, and A. Taraboulos Sphingolipid Depletion Increases Formation of the Scrapie Prion Protein in Neuroblastoma Cells Infected with Prions J. Biol. Chem., July 23, 1999; 274(30): 20763 - 20771. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Prusiner Prions PNAS, November 10, 1998; 95(23): 13363 - 13383. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Tremblay, Z. Meiner, M. Galou, C. Heinrich, C. Petromilli, T. Lisse, J. Cayetano, M. Torchia, W. Mobley, H. Bujard, et al. Doxycycline control of prion protein transgene expression modulates prion disease in mice PNAS, October 13, 1998; 95(21): 12580 - 12585. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Caspi, M. Halimi, A. Yanai, S. B. Sasson, A. Taraboulos, and R. Gabizon The Anti-prion Activity of Congo Red. PUTATIVE MECHANISM J. Biol. Chem., February 6, 1998; 273(6): 3484 - 3489. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Hegde, J. A. Mastrianni, M. R. Scott, K. A. DeFea, P. Tremblay, M. Torchia, S. J. DeArmond, S. B. Prusiner, and V. R. Lingappa A Transmembrane Form of the Prion Protein in Neurodegenerative Disease Science, February 6, 1998; 279(5352): 827 - 834. [Abstract] [Full Text] |
||||
![]() |
M. R. Scott, J. Safar, G. Telling, O. Nguyen, D. Groth, M. Torchia, R. Koehler, P. Tremblay, D. Walther, F. E. Cohen, et al. Identification of a prion protein epitope modulating transmission of bovine spongiform encephalopathy prions to transgenic mice PNAS, December 23, 1997; 94(26): 14279 - 14284. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Prusiner Prion Diseases and the BSE Crisis Science, October 10, 1997; 278(5336): 245 - 251. [Abstract] [Full Text] |
||||
![]() |
K. Kaneko, L. Zulianello, M. Scott, C. M. Cooper, A. C. Wallace, T. L. James, F. E. Cohen, and S. B. Prusiner Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation PNAS, September 16, 1997; 94(19): 10069 - 10074. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kaneko, M. Vey, M. Scott, S. Pilkuhn, F. E. Cohen, and S. B. Prusiner COOH-terminal sequence of the cellular prion protein directs subcellular trafficking and controls conversion into the scrapie isoform PNAS, March 18, 1997; 94(6): 2333 - 2338. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Naslavsky, R. Stein, A. Yanai, G. Friedlander, and A. Taraboulos Characterization of Detergent-insoluble Complexes Containing the Cellular Prion Protein and Its Scrapie Isoform J. Biol. Chem., March 7, 1997; 272(10): 6324 - 6331. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Shetty and R. W. Steele Commentary Review: Prion Diseases Clinical Pediatrics, January 1, 1997; 36(1): 1 - 7. [PDF] |
||||
![]() |
M. Vey, S. Pilkuhn, H. Wille, R. Nixon, S. J. DeArmond, E. J. Smart, R. G. W. Anderson, A. Taraboulos, and S. B. Prusiner Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains PNAS, December 10, 1996; 93(25): 14945 - 14949. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.J. DeArmond, Y. Qiu, K. Wong, R. Nixon, W. Hyun, S.B. Prusiner, and W.C. Mobley Abnormal Plasma Membrane Properties and Functions in Prion-infected Cell Lines Cold Spring Harb Symp Quant Biol, January 1, 1996; 61(0): 531 - 540. [Abstract] [PDF] |
||||
![]() |
D Westaway, V Zuliani, C M Cooper, M Da Costa, S Neuman, A L Jenny, L Detwiler, and S B Prusiner Homozygosity for prion protein alleles encoding glutamine-171 renders sheep susceptible to natural scrapie. Genes & Dev., April 15, 1994; 8(8): 959 - 969. [Abstract] [PDF] |
||||
![]() |
R Hecker, A Taraboulos, M Scott, K M Pan, S L Yang, M Torchia, K Jendroska, S J DeArmond, and S B Prusiner Replication of distinct scrapie prion isolates is region specific in brains of transgenic mice and hamsters. Genes & Dev., July 1, 1992; 6(7): 1213 - 1228. [Abstract] [PDF] |
||||
![]() |
Y.-S. Ying, R.G.W. Anderson, and K.G. Rothberg Each Caveola Contains Multiple Glycosyl-phosphatidylinositol-anchored Membrane Proteins Cold Spring Harb Symp Quant Biol, January 1, 1992; 57(0): 593 - 604. [Abstract] [PDF] |
||||
![]() |
S. Prusiner Molecular biology of prion diseases Science, June 14, 1991; 252(5012): 1515 - 1522. [Abstract] [PDF] |
||||
![]() |
K. Hsiao, M Scott, D Foster, D. Groth, S. DeArmond, and S. Prusiner Spontaneous neurodegeneration in transgenic mice with mutant prion protein Science, December 14, 1990; 250(4987): 1587 - 1590. [Abstract] [PDF] |
||||
![]() |
G. M. Shaked, Y. Shaked, Z. Kariv-Inbal, M. Halimi, I. Avraham, and R. Gabizon A Protease-resistant Prion Protein Isoform Is Present in Urine of Animals and Humans Affected with Prion Diseases J. Biol. Chem., August 17, 2001; 276(34): 31479 - 31482. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Meyer, A. Lustig, B. Oesch, R. Fatzer, A. Zurbriggen, and M. Vandevelde A Monomer-Dimer Equilibrium of a Cellular Prion Protein (PrPC) Not Observed with Recombinant PrP J. Biol. Chem., November 22, 2000; 275(48): 38081 - 38087. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |